We are perfluorodecalin CAS:306-94-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Synonyms：
OCTADECAFLUORODECALIN
Octadecafluorodecaline
perfluorodecahydronaphthalene
Naphthalene, octadecafluorodecahydro-
Perfluoro(decahydronaphthalene)
perfluorodecahydronaphthalin
1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8,8a-octadecafluorodecalin
perflunafene
PP 5
PERFLUORODECALIN
PERFLUORODECALINE
Octadecafluorodecahydronaphthalene
Molecular Formula: C10F18
Molecular weight： 462.07800
Appearance and properties: transparent colorless transparent liquid
Density: 1.9
Boiling point: 142ºC
Melting point: -10ºC
Flash point: 40ºC
Refractive index: 1.3135-1.3155
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.
Market News: In addition, AstraZeneca is exploring the potential of anifrolumab in a variety of diseases where type I interferon plays a key role, including lupus nephritis, cutaneous lupus erythematosus and myositis.Thalrugosaminine manufacturer.In SLE, along with the pivotal TULIP phase III programme, anifrolumab continues to be evaluated in a long-term extension phase III trial.12 A phase II trial of anifrolumab in SLE using subcutaneous delivery has been completed. 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline supplier Mindset was established in order to develop next generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. ethyl 6,7-bis(cyclopropylmethoxy)-4-oxo-1H-quinoline-3-carboxylate producer
